BioWorld

March 30, 2000

View Archived Issues

Helix Raises C$22.75M To Fund Development Of Three Projects

Read More

Other News To Note

Read More

Cytogen Plans $50.9M Stock Offering To Boost PSMA Work

Read More

Long-Fought Amgen-TKT Case Back In Federal Court In Boston

Read More

Cellegy Enters Pivotal Phase III Trial On Low-Testosterone Gel

Read More

Cell Therapeutics Files NDA For Drug Treating Relapsed Leukemia

Read More

Putting Methylation, Epigenesis And Imprinting Of Genes Into Picture of Future Medical Practice

Read More

NeoTherapeutics Starts Phase II/III Trial Of Neotrofin In Alzheimer's

Read More

Researchers Complete Two-Thirds Of Base Pairs In Genome Project

Read More

Management Challenges For Biotech In The 21st Century

Read More